David W. Keiser

Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Selexys Pharmaceuticals Corp. operates as a biopharmaceutical company, which focuses on development of therapeutics for the treatment of inflammation, thrombosis and metastasis across a broad range of severe diseases. The firm solutions are used to treat vasoocclusion and thrombosis, such as vasoocclusive pain crisis in sickle cell disease and deep venous thrombosis; chronic inflammatory diseases and formation of atherosclerotic plaques. The company was founded by Richard D. Cummings, Richard Alvarez and Rodger P. McEver in 2002 and is headquartered in Oklahoma, OK.

G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985.

Mundipharma Medical Co. develops and markets pharmaceutical products. It focuses on analgesics, antiseptics and oncology preparations and also acts as a licensing company for the Purdue, Mundipharma, and Napp companies. The company was founded in 1957 and is headquartered in Basel, Switzerland.